期刊文献+

肺腺癌组织中VEGF mRNA的表达与外周血微转移的关系 被引量:1

Relationship between VEGF mRNA expression in lung adenocarcinoma tissues and micrometastasis in peripheral blood
原文传递
导出
摘要 目的探讨肺腺癌组织中血管内皮生长因子(VEGF)mRNA的表达与外周血微转移的关系。方法应用RT-PCR方法检测33例肺腺癌组织中VEGF mRNA和外周静脉血中CK19 mRNA表达变化。另选10例正常人外周血为对照。结果 33例肺腺癌组织中VEGF mRNA的阳性率为78.79%(26/33),外周血CK19 mRNA的阳性率为57.58%(19/33);10例正常人外周血无CK19 mRNA阳性表达。肺腺癌组织中VEGF mRNA的表达与淋巴结转移和病理分期密切相关;VEGF mRNA高表达者与VEGF mRNA低表达者CK19的阳性率有显著性差异(P<0.05)。结论肺腺癌患者组织中VEGF mRNA表达和淋巴结及血行转移关系密切;联合检测肺腺癌组织中VEGF mRNA和外周血CK19 mRNA的表达有助于评估肺癌转移、病理分期及预后。 Objective To investigate the relationship of vascular endothelial growth factor(VEGF) mRNA expression with micrometastasis in peripheral blood. Methods The expressions of VEGF mRNA in lung adenocarcinoma tissue and CK19 mRNA in peripheral blood were detected by RT-PCR in 33 patients with lung adenocarcinoma(group A).The expression of CK19 mRNA in peripheral blood was detected in 10 healthy adults as the control (group C).Results The positive expression of VEGF mRNA was 78.79%(26/33) in lung adenocarcinoma and that of CK19 mRNA was 57.58%(19/33) in peripheral blood in group A.The expression of CK19 mRNA in peripheral blood in group C was zero.VEGF mRNA expression in lung adenocarcinoma was closely related to pathological stage and lymph node metastasis.CK19 mRNA expression was significantly different between the patients with high and low expression of VEGF mRNA(P0.05).Conclusion The VEGF mRNA expression in lung adenocarcinoma is closely related to lymph node and hematogenous metastasis.Combined detection of VEGF mRNA expression in lung adenocarcinoma and CK19 mRNA expression in peripheral blood is helpful in evaluating metastasis,pathological stage and prognosis in patients with lung adenocarcinoma.
出处 《江苏医药》 CAS CSCD 北大核心 2010年第19期2271-2273,共3页 Jiangsu Medical Journal
关键词 肺腺癌 血管内皮生长因子 CK19 Lung adenocarcinoma Vascular endothelial growth factor CK19
  • 相关文献

参考文献10

  • 1Sugio K, Kase S, Sakada T, et al. Micrometastasis in the bone marrow of patients with lung cancer associated with a reduced expression of E-cadherin and beta-catenin: risk assessment by immunohistochemistry[J]. Surgery, 2002, 131 (1 Suppt):226-231.
  • 2Toshihiro BY,Osaki T,Oyama T, et al. Prognostic impact of micrometastatic tumor cells in the lymph nodes and bone marrow of patients with completely resected stage Ⅰ nonsmall cell lung cancer[J]. J Ctin Oncol, 2002, 20 (13) : 2930- 2936.
  • 3查小明,武正炎,范萍,王水.逆转录多聚酶链反应方法研究乳腺癌的微小转移[J].江苏医药,2001,27(2):93-95. 被引量:4
  • 4Datta YH, Adams PT, Drobyski WR, et al. Sensitive detection of occult breast cancer by reverse-transcriptase polymerase chain reaction[J]. J Clin Oncol, 1994,12 (3) :475-482.
  • 5Sher YP, Adams PT, Drobyski WR, et al. Prognosis of nonsmall cell lung cancer patients by detecting circulating cancer cells in the peripheral blood with multiple marker genes[J]. Clin Cancer Res,2005,11(1):173-179.
  • 6Fontanini G, Boldrini L, Chine S, et al. Expression of vascular endothelial growth factor mRNA in non-small cell lung cancer[J]. Br J Cancer, 1999,72(2) : 363-369.
  • 7万锦平,黄建安,穆传勇,刘皓,鲁常青.ESM-1、VEGF在非小细胞肺癌中的表达及意义[J].江苏医药,2008,34(9):900-902. 被引量:3
  • 8Yuan A, Yu CJ, Chen WJ, et al. Correlation of total VEGF mRNA and protein expression with histologic type, tumor angiogenesis, patient survival and timing of relapse in non- small-cell lung cancer[J]. Int J Cancer, 2000,89 (6) : 475-483.
  • 9Shou Y, Hirano T, Gong Y, et al. Influence of angiogenetic factors and matrix metalloproteinases upon tumour progression in non-small-cell lung cancer[J]. Br J Cancer, 2001, 85 (11):1706-1712.
  • 10董强刚,冯久贤,黄进肃,包国良,沙慧芳,顾伟勇.血管内皮生长因子对非小细胞肺癌血道转移的影响[J].中华肿瘤杂志,2002,24(2):142-146. 被引量:17

二级参考文献12

  • 1邢伟,张晓膺,孙益芳,俞逵仑.动态增强MRI在评价非小细胞肺癌血管生成中的临床价值[J].江苏医药,2005,31(10):754-756. 被引量:4
  • 2武正炎 杜竞辉 等.免疫组化法检测乳腺癌患者骨髓内转移癌细胞[J].南京医学院学报,1989,4:296-297.
  • 3Ruud P,Int J Cancer,1999年,80卷,119页
  • 4Traweek S T,Am J Pathol,1993年,142卷,1111页
  • 5武正炎,南京医学院学报,1989年,4卷,296页
  • 6Sarrazin S, Adam E, Lyon M, et al. Endocan or endothelial cell specific molecule-1 (ESM-1):a potential novel endothelial cell marker and a new target for cancer therapy[J]. Biochim Biophys Acta, 2006, 1765(1) :25 37.
  • 7Scherpereel A, Gentina T,Grigoriu B, et al. Overexpression of endocan induces tumor formation[J]. Cancer Res, 2003,63 (18) : 6084-6089.
  • 8Borczuk A, Shah L, Pearson G, et al. Molecular signatures in biopsy specimens of lung cancer[J]. Am J Resp Crit Care Med, 2004,170(2) : 167-174.
  • 9Fontanini G. Vascular endothelia growth factor is associated with neovaseularition and influences progression of non small cell lung carcinoma[J]. Cancer Res, 1997,3(6):8011-1524.
  • 10Uthoff SM, Duchrow M, Schrnidt MH, et al. VEGF isoforms and mutations in human colorectal cancer[J]. Int J Cancer, 2002,101(1) :32-36.

共引文献21

同被引文献9

  • 1Lee WS,Chun HK,Lee WY,et al.Treatment outcomes inpatients with signet ring cell carcinoma of the colorectum[J].Am J Surg,2007,194(3):294-298.
  • 2Moug SJ,Saldanha JD,McGregor JR,et al.Positive lymphnode retrieval ratio optimises patient staging in colorectalcancer[J].Br J Cancer,2009,100(10):1530-1533.
  • 3Lee HY,Choi HJ,Park KJ,et al.Prognostic significance ofmetastatic lymph node ratio in node-positive colon carcinoma[J].Ann Surg Oncol,2007,14(5):1712-1717.
  • 4Silva JM,Rodriguez R,Garcia JM,et al.Detection of epithelialtumour RNA in the plasma of colon cancer patients is associ-ated with advanced stages and circulating tumour cells[J].Gut,2002,50(4):530-534.
  • 5Taniyama K,Motoshita J,Sakane J,et al.Combination analy-sis of a whole lymph node by one-step nucleic acid amplifica-tion and histology for intraoperative detection of micrometas-tasis[J].Pathobiology,2006,73(4):183-191.
  • 6Nguyen MD,Plasil B,Wen P,et al.Mucin profiles in signet-ring cell carcinoma[J].Arch Pathol Lab Med,2006,130(6):799-804.
  • 7Gopalan V,Smith RA,Ho YH,et al.Signet-ring cell carcino-ma of colorectum--current perspectives and molecular biology[J].Int J Colorectal Dis,2011,26(2):127-133.
  • 8Boland CR,Goel A.Microsatellite instability in colorectalcancer[J].Gastroenterology,2010,138(6):2073-2087.
  • 9俞晓峰,丁永斌,夏建国,翟竞,梁辉,管蔚.胃印戒细胞癌临床病理特点分析[J].江苏医药,2010,36(22):2628-2630. 被引量:10

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部